This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

A demo car ad created with Veo 2 from Google DeepMind is so realistic that it's hard to spot the amazing locations, ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

The director of the corporation’s scientific laboratory points to genomics, nuclear fusion and the development of new ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...

Video generation models and software advanced significantly in 2024, a year capped by impressive model updates to Google ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...